GlassScriptPhysician profile
Colette Shiu
NPI 1508325382
$1,696.67
in general payments reported to CMS, 2019-2025
12 companies · $300 in 2025
The $300 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $33.52 · 2023: $854 · 2024: $508 · 2025: $300.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,663.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,663.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $453.06 | 2023-2025 | Arexvy, Bexsero, Shingrix |
| Amgen INC. | $266.08 | 2023-2025 | Evenity, Repatha, Otezla |
| Lilly USA, LLC | $210.38 | 2023-2025 | Mounjaro, Zepbound, Jardiance |
| Idorsia Pharmaceuticals US INC | $167.06 | 2023 | Quviviq |
| Kaleo, INC. | $125.00 | 2024 | Auvi-Q |
| Abbott Laboratories | $121.37 | 2025 | Freestyle Libre 3 |
| Novo Nordisk INC | $90.24 | 2023-2025 | Rybelsus, Ozempic, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $86.23 | 2023-2025 | Jardiance |
| Pfizer INC. | $73.55 | 2023-2025 | |
| Abbvie INC. | $72.16 | 2022-2023 | Ubrelvy |
| Bayer Healthcare Pharmaceuticals INC. | $17.69 | 2023 | |
| Novartis Pharmaceuticals Corporation | $13.85 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Colette Shiu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.